Is Pluri, Inc. technically bullish or bearish?
2025-09-20 19:27:02As of 12 September 2025, the technical trend for Pluri, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. The weekly RSI is bearish, and both the weekly and monthly Bollinger Bands indicate bearish conditions. Daily moving averages show a mildly bullish trend. The KST is mildly bearish on a weekly basis and bearish monthly, while the Dow Theory shows no trend weekly and mildly bearish monthly. In terms of performance, Pluri, Inc. has underperformed compared to the S&P 500 across multiple periods, with a 1-week return of -12.41% versus the S&P 500's 1.05%, and a 1-year return of -13.35% compared to 17.14% for the index....
Read MoreIs Pluri, Inc. overvalued or undervalued?
2025-09-20 18:03:02As of 13 May 2025, the valuation grade for Pluri, Inc. has moved from does not qualify to risky, indicating a deteriorating outlook. The company is overvalued, as reflected by its negative Price to Book Value of -8.32 and an EV to EBITDA ratio of -1.69, both of which suggest significant financial distress. Additionally, the EV to Sales ratio stands at 34.89, indicating that the market is pricing the company at an extremely high multiple relative to its sales. In comparison to its peers, Pluri, Inc. has a less favorable EV to EBITDA ratio than Equillium, Inc. at -4.9420 and OncoCyte Corp. at -2.1276, highlighting its relative weakness within the industry. Furthermore, the company's recent stock performance has been poor, with a 1-year return of -13.35% compared to the S&P 500's 17.14%, reinforcing the notion that Pluri, Inc. is struggling significantly in the market....
Read More





